Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Merck Sharp & Dohme LLC · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
carcinoma
carcinoma, non-small-cell lung, programmed cell death-1 (pd1, pd-1), programmed cell death 1 ligand 1 (pdl1, pd-l1), programmed cell death 1 ligand 2 (pdl2, pd-l2), individualized neoantigen therapy (int), interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 841484
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.